A. Albillos

437 total citations
27 papers, 264 citations indexed

About

A. Albillos is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, A. Albillos has authored 27 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hepatology, 16 papers in Epidemiology and 10 papers in Surgery. Recurrent topics in A. Albillos's work include Liver Disease and Transplantation (16 papers), Liver Disease Diagnosis and Treatment (13 papers) and Organ Transplantation Techniques and Outcomes (5 papers). A. Albillos is often cited by papers focused on Liver Disease and Transplantation (16 papers), Liver Disease Diagnosis and Treatment (13 papers) and Organ Transplantation Techniques and Outcomes (5 papers). A. Albillos collaborates with scholars based in Spain, Italy and France. A. Albillos's co-authors include P Escartín, C. Barrios, Juan G. Abraldeṣ, Valentín Cuervas‐Mons, I. Millán, Rafael Bañares, Juan Carlos García‐Pagán, Matthias Dollinger, Rajiv Jalan and Frederik Nevens and has published in prestigious journals such as Gastroenterology, Journal of Hepatology and Critical Care.

In The Last Decade

A. Albillos

22 papers receiving 257 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Albillos Spain 8 219 169 105 27 21 27 264
Joseph J. Alukal United States 11 137 0.6× 165 1.0× 80 0.8× 11 0.4× 36 1.7× 31 274
Junna Dai China 13 468 2.1× 419 2.5× 207 2.0× 20 0.7× 14 0.7× 13 518
Arthur A. Dunk United Kingdom 6 300 1.4× 273 1.6× 118 1.1× 18 0.7× 16 0.8× 8 356
Juan Canabal United States 9 121 0.6× 64 0.4× 143 1.4× 18 0.7× 28 1.3× 22 245
Mjh Slooff Italy 7 153 0.7× 73 0.4× 193 1.8× 12 0.4× 26 1.2× 27 326
Giulia Tosetti Italy 10 255 1.2× 246 1.5× 69 0.7× 20 0.7× 5 0.2× 26 297
Frances Sheppard France 7 171 0.8× 174 1.0× 61 0.6× 14 0.5× 7 0.3× 8 281
Giovanni Talerico Italy 7 194 0.9× 189 1.1× 81 0.8× 14 0.5× 11 0.5× 11 310
María Isabel Jirón Chile 9 282 1.3× 239 1.4× 141 1.3× 20 0.7× 25 1.2× 18 362
Laura Lemma Italy 7 264 1.2× 217 1.3× 92 0.9× 23 0.9× 15 0.7× 8 367

Countries citing papers authored by A. Albillos

Since Specialization
Citations

This map shows the geographic impact of A. Albillos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Albillos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Albillos more than expected).

Fields of papers citing papers by A. Albillos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Albillos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Albillos. The network helps show where A. Albillos may publish in the future.

Co-authorship network of co-authors of A. Albillos

This figure shows the co-authorship network connecting the top 25 collaborators of A. Albillos. A scholar is included among the top collaborators of A. Albillos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Albillos. A. Albillos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Magaz, Marta, Neil Rajoriya, Constantino Fondevila, et al.. (2021). Liver Transplant for Porto-sinusoidal Vascular Disease: Long-term Outcome. HPB. 23. S950–S951.
2.
Elkrief, Laure, Lucile Moga, Michael Praktiknjo, et al.. (2018). Prognosis after abdominal surgery in patients with idiopathic non-cirrhotic portal hypertension: A multicenter retrospective study. Journal of Hepatology. 68. S697–S697. 1 indexed citations
3.
Muñoz‐Bellvís, Luis, et al.. (2017). Simvastatin neither reduces gut bacterial translocation nor sistemic/mesenteric inflammation in cirrhotic rats with ascites. Journal of Hepatology. 66(1). S147–S147. 1 indexed citations
4.
Albillos, A., et al.. (2017). Treatment of patients with hepatitis C virus genotype 5 and 6: descriptive analysis of the Hepa-C registry. Journal of Hepatology. 66(1). S720–S720.
5.
Turco, Laura, Càndid Villanueva, Vincenzo La Mura, et al.. (2017). A reduction in the hepatic venous pressure gradient (HVPG) prevents clinical outcomes in compensated and decompensated cirrhosis: a meta-analysis. Journal of Hepatology. 66(1). S103–S104. 2 indexed citations
6.
Muñoz‐Bellvís, Luis, M. Lario, Elia Aguado-Fraile, et al.. (2014). P29 COMMENSAL BACTERIA DRIVES THE EXPANSION OF PROINFLAMMATORY T-LYMPHOCYTES IN THE SMALL INTESTINAL MUCOSA AND WORSENS THE EPITHELIAL BARRIER FUNCTION IN CCl4 CIRRHOTIC RATS WITH ASCITIS. Journal of Hepatology. 60(1). S76–S76. 1 indexed citations
8.
Seijó, Susana, Maria Delgado, Ismael Yepes, et al.. (2012). 106 EFFICACY AND SAFETY OF ANTICOAGULATION IN PATIENTS WITH CIRRHOSIS AND PORTAL VEIN THROMBOSIS. Journal of Hepatology. 56. S47–S47. 65 indexed citations
10.
Albillos, A., et al.. (2009). Seguimiento endoscópico de la úlcera gástrica en una población de riesgo intermedio de cáncer gástrico. Revista Española de Enfermedades Digestivas. 101(5). 7 indexed citations
11.
Abraldeṣ, Juan G., A. Albillos, Juan Turnés, et al.. (2008). 55 HEMODYNAMIC EFFECTS AND SAFETY OF ONE-MONTH SIMVASTATIN TREATMENT IN PATIENTS WITH CIRRHOSIS AND PORTAL HYPERTENSION. A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED MULTICENTER TRIAL. Journal of Hepatology. 48. S25–S25. 2 indexed citations
12.
Albillos, A., Nicolas Carbonell, Julien Massard, et al.. (2007). [785] RECOMBINANT FACTOR VIIA (RFVIIA) FOR ACTIVE VARICEAL BLEEDING IN PATIENTS WITH ADVANCED CIRRHOSIS: A MULTI-CENTRE RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL. Journal of Hepatology. 46. S295–S296. 14 indexed citations
15.
Albillos, A., et al.. (2001). Randomized comparison of long-term Losartan vs propranolol in lowering portal pressure in cirrhosis. Journal of Hepatology. 34. 17–17. 2 indexed citations
16.
Barrios, Clara, et al.. (1993). Renin-angiotensin-aldosterone system and arterial hypertension following orthotopic liver transplantation.. PubMed. 25(2). 1768–1768. 1 indexed citations
17.
Sánchez-Turrión, Víctor, Valentín Cuervas‐Mons, Francisca Portero, et al.. (1993). Prospective study of the incidence, timing, significance, risk factors, and outcome of cytomegalovirus infection in liver transplant patients with double-drug immunosuppression and no prophylactic antiviral therapy.. PubMed. 25(2). 1786–1786. 1 indexed citations
18.
Cuervas‐Mons, Valentín, Javier A. Menéndez, C. Barrios, et al.. (1991). Value of histologic findings in predicting the response to treatment of acute graft rejection after liver transplantation.. PubMed. 23(3). 1972–1972. 2 indexed citations
19.
Albillos, A., et al.. (1990). Ascitic fluid polymorphonuclear cell count and serum to ascites albumin gradient in the diagnosis of bacterial peritonitis. Gastroenterology. 98(1). 134–140. 71 indexed citations
20.
Albillos, A., et al.. (1988). Study of the secretion of pepsinogen I in cirrhotic humans with and without portacaval shunt.. PubMed. 83(1). 37–41. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026